[Selective inhibitors of plasmepsin II from Plasmodium falciparum based on pepstatin]. 2008

L D Rumsh, and A G Mikhaĭlova, and I V Mikhura, and I A Prudchenko, and L D Chikin, and I I Mikhaleva, and E N Kaliberda, and N I Dergousova, and E E Mel'nikov, and A A Formanovskiĭ
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, Moscow, 117997 Russia. rumsh@enzyme.siobc.ras.ru

A number of new inhibitors of plasmepsin II (PlmII) from Plasmodium falciparum, one of the key factors of malarial parasite survival, were synthesized. The inhibitors are analogues of pepstatin with various variants of Ala residue substitutions. Effects of the inhibitors on human PlmII and cathepsin D were studied. Inhibition of PlmII by the substrate was found, which required the use of the modified Henderson method for the determination of inhibition constants. Two synthesized inhibitors were shown to exhibit a pronounced selectivity to PlmII (K(i) = 5.5 and 5 nM) in comparison with cathepsin D (K(i) = 230 and 3000 nM, respectively).

UI MeSH Term Description Entries
D010436 Pepstatins N-acylated oligopeptides isolated from culture filtrates of Actinomycetes, which act specifically to inhibit acid proteases such as pepsin and renin.
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D002402 Cathepsin D An intracellular proteinase found in a variety of tissue. It has specificity similar to but narrower than that of pepsin A. The enzyme is involved in catabolism of cartilage and connective tissue. EC 3.4.23.5. (Formerly EC 3.4.4.23).
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015800 Protozoan Proteins Proteins found in any species of protozoan. Proteins, Protozoan
D016282 Aspartic Acid Endopeptidases A sub-subclass of endopeptidases that depend on an ASPARTIC ACID residue for their activity. Aspartic Endopeptidases,Aspartyl Endopeptidases,Acid Endopeptidases, Aspartic,Endopeptidases, Aspartic Acid,Endopeptidases, Aspartyl

Related Publications

L D Rumsh, and A G Mikhaĭlova, and I V Mikhura, and I A Prudchenko, and L D Chikin, and I I Mikhaleva, and E N Kaliberda, and N I Dergousova, and E E Mel'nikov, and A A Formanovskiĭ
December 2015, Acta crystallographica. Section F, Structural biology communications,
L D Rumsh, and A G Mikhaĭlova, and I V Mikhura, and I A Prudchenko, and L D Chikin, and I I Mikhaleva, and E N Kaliberda, and N I Dergousova, and E E Mel'nikov, and A A Formanovskiĭ
August 2003, Bioorganic & medicinal chemistry,
L D Rumsh, and A G Mikhaĭlova, and I V Mikhura, and I A Prudchenko, and L D Chikin, and I I Mikhaleva, and E N Kaliberda, and N I Dergousova, and E E Mel'nikov, and A A Formanovskiĭ
September 1998, Bioorganic & medicinal chemistry letters,
L D Rumsh, and A G Mikhaĭlova, and I V Mikhura, and I A Prudchenko, and L D Chikin, and I I Mikhaleva, and E N Kaliberda, and N I Dergousova, and E E Mel'nikov, and A A Formanovskiĭ
June 2003, Current medicinal chemistry,
L D Rumsh, and A G Mikhaĭlova, and I V Mikhura, and I A Prudchenko, and L D Chikin, and I I Mikhaleva, and E N Kaliberda, and N I Dergousova, and E E Mel'nikov, and A A Formanovskiĭ
February 2003, Journal of medicinal chemistry,
L D Rumsh, and A G Mikhaĭlova, and I V Mikhura, and I A Prudchenko, and L D Chikin, and I I Mikhaleva, and E N Kaliberda, and N I Dergousova, and E E Mel'nikov, and A A Formanovskiĭ
May 2002, Phytochemistry,
L D Rumsh, and A G Mikhaĭlova, and I V Mikhura, and I A Prudchenko, and L D Chikin, and I I Mikhaleva, and E N Kaliberda, and N I Dergousova, and E E Mel'nikov, and A A Formanovskiĭ
October 2016, Biochimica et biophysica acta,
L D Rumsh, and A G Mikhaĭlova, and I V Mikhura, and I A Prudchenko, and L D Chikin, and I I Mikhaleva, and E N Kaliberda, and N I Dergousova, and E E Mel'nikov, and A A Formanovskiĭ
April 2014, Fitoterapia,
L D Rumsh, and A G Mikhaĭlova, and I V Mikhura, and I A Prudchenko, and L D Chikin, and I I Mikhaleva, and E N Kaliberda, and N I Dergousova, and E E Mel'nikov, and A A Formanovskiĭ
January 2018, PloS one,
L D Rumsh, and A G Mikhaĭlova, and I V Mikhura, and I A Prudchenko, and L D Chikin, and I I Mikhaleva, and E N Kaliberda, and N I Dergousova, and E E Mel'nikov, and A A Formanovskiĭ
September 1996, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!